Evidence map›Paper›PMID 32831459›Full record

ArticleJournal of statistical planning and inference2020

A single-index model with multiple-links.

Hyung Park, Eva Petkova, Thaddeus Tarpey, R Todd Ogden

Registry-linked trialAbstract read
In one paragraph

Article in Journal of statistical planning and inference, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05025787 (EN20-01), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05025787 phase2completednot on this mapstarted 2021, after this paper: background citation

EN20-01: A 24 Week Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Moderate to Severe Knee Osteoarthritis Pain.

TypeinterventionalSponsorMaurizio Fava, MDRan2021 to 2024Enrolled55ConditionsKnee OsteoarthritisArmsCNTX-6970, Placebo
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyung ParkDepartment of Population Health, New York University, New York, NY 10016, U.S.A.
Eva PetkovaDepartment of Population Health, New York University, New York, NY 10016, U.S.A.
Thaddeus TarpeyDepartment of Population Health, New York University, New York, NY 10016, U.S.A.
R Todd OgdenDepartment of Biostatistics, Columbia University, New York, NY 10032, U.S.A.

Funding

Characterizing Placebo ResponseR01MH099003 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PETKOVA, EVA, TARPEY, THADDEUS · 2013 to 2021
$4.5M
2/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) –DCCU24HL155811 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI THADDEUS TARPEY, Andrea B Troxel · 2022 to 2026
$2.8M
NHLBI NIH HHS U24 HL155811NIMH NIH HHS R01 MH099003
6 · The paper itself

Abstract

In a regression model for treatment outcome in a randomized clinical trial, a treatment effect modifier is a covariate that has an interaction with the treatment variable, implying that the treatment efficacies vary across values of such a covariate. In this paper, we present a method for determining a composite variable from a set of baseline covariates, that can have a nonlinear association with the treatment outcome, and acts as a composite treatment effect modifier. We introduce a parsimonious generalization of the

Indexed as

BiosignatureSingle-index modelsTreatment effect modifier

Identifiers

PMID32831459
PMCPMC7441812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.